Engine smoke grounds plane on Tokyo runway
A Korean Air Lines plane preparing to take off from a Tokyo airport had to evacuate its passengers after smoke came out of its left engine. Rough cut (no reporter narration).
A Korean Air Lines plane preparing to take off from a Tokyo airport had to evacuate its passengers after smoke came out of its left engine. Rough cut (no reporter narration).
Tesla said it would "accelerate" the launch of new models next year, including lower-cost cars, countering reports earlier this month it had scraped those plans.
Tony DeAngelo found himself playing a reduced role in his second stint with the Carolina Hurricanes amid a deep roster of defensemen. DeAngelo worked in a pairing with Brady Skjei during practice Wednesday before the Hurricanes traveled north ahead of Game 3 against the New York Islanders on Thursday.
The big U.S. aid package for Ukraine and other allies that President Joe Biden signed Wednesday also allows the administration to seize Russian state assets located in the U.S. and use them for the benefit of Kyiv. The seizures would be carried out under provisions of the REPO Act, short for the Rebuilding Economic Prosperity and Opportunity for Ukrainians Act, that were incorporated into the aid bill.
HOUSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) announced today that it will report first quarter 2024 financial and operating results after the U.S. financial markets close on May 8, 2024. Management will host a conference call at 10:00 a.m. CT on May 9, 2024 to discuss the Company’s results. Interested parties are invited to participate in the conference call by dialing (800) 901-2707 (Conference ID: AEC1Q24) at least 15 minutes prior
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that topline clinical data from the monotherapy and combination dose escalation portion of its Phase 1/2 trial of SNS-101, a conditionally active, human monoclonal antibody targeting the immune checkpoint VISTA (V-domain Ig suppressor of T cell activation), wil
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract has been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held May 31-June 4, 2024, in Chicago, Il. The abstract highlights results from a recent study that Predictive Oncology completed in collaboration with UPMC Magee-Womens Hospital in Pittsburgh, PA. The stu
MCLEAN, Va., April 24, 2024 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will host a conference call the same day at 5:00 PM ET to discuss its results. Registration for the conference call can be completed by visiting the following website prior to, or on the
Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presentedSOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics and biopharmaceutical company, today announced that two abstracts on 23ME-00610, a first-in-class anti-CD200R1 antibody, have been accepted for poster presentations at the 2024 ASCO Annual Meeting, taking place May 31 - June 4 in Chicago. 23an
EL SEGUNDO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the first quarter 2024 ended March 30, 2024 on Wednesday, May 8, 2024 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. Eastern, 2:00 p.m. Pacific. Investors interested in participating in the live call can dial 412-902-4255. There will also be a
MCLEAN, Va., April 24, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced that it will release financial results for the first quarter ended March 31, 2024, before the U.S. financial markets open on Thursday, May 2, 2024. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this Registration Link. Once registered, p
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and supports detection and management of antimicrobial resistance, critical needs in TB surveillance and control // Building upon success of leading diagnostics test QuantiFERON-TB Gold Plus as QIAGEN extends portfolio for TB management and control amid globally rising incidence ratesVenlo, the Netherla
LARGO, Fla., April 24, 2024--CONMED Corporation (NYSE: CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.
DUNMORE, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- On April 24, 2024, the Board of Directors of FNCB Bancorp, Inc. (NASDAQ:FNCB) declared a dividend of $0.090 per share for the second quarter of 2024. The second quarter 2024 dividend is payable on June 17, 2024 to shareholders of record as of June 3, 2024. Year-to-date dividends declared in 2024 total $0.18 per share. About FNCB Bancorp, Inc.: FNCB Bancorp, Inc. is the bank holding company of FNCB Bank. Locally-based for over 114 years, FNCB Bank
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of April 15, 2024, short interest in 3,081 Nasdaq Global MarketSM securities totaled 11,407,213,969 shares compared with 11,297,406,980 shares in 3,102 Global Market issues reported for the prior settlement date of March 28, 2024. The mid-April short interest represents 3.20 days compared with 2.78 days for the prior reporting period. Short interest in 1,722 securities on The Nasdaq Capital MarketSM totaled 1,895,119,
WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of two abstracts for poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31 – June 4 in Chicago, IL as well as virtually. Poster Presentati
DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced that it has appointed a new Chief Financial Officer, Darin Harper, who will join the Company on June 17, 2024. The Company’s existing Chief Financial Officer, Michael Quartieri, will continue to serve as Chief Financial Officer until June 16, 2024 to ensure a smooth transition to his success
BUFFALO, N.Y., April 24, 2024 (GLOBE NEWSWIRE) -- ACV (Nasdaq: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2024 financial results after market close and host a conference call at 5:00 p.m. ET on Wednesday, May 8, 2024. Investors and analysts interested in participating in the call are invited to dial 877-704-4453 (international callers please dial 1-201-389-0920) approxima
Earnings Release: Monday, April 29, 2024, After Market Closes Conference Call and Webcast: Tuesday, April 30, 2024, at 10:00 A.M. Eastern Time MONACO, April 24, 2024 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it will release its results for the first quarter ended March 31, 2024, after the market closes in New York on Monday, April 29, 2024. On Tuesday, April 30, 2024, at 10:00 A.M. Ea
NORWOOD, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that an abstract providing updated data from the Phase 1, first-in-human clinical data from a dose escalation study being carried out by its partner CSPC in China with CRB-701 (SYS6002) has been accepted for presentation at the 2024 American Society of Clinical Oncology annual meeting, to be held May 31-June 4, 2024 in Chicago, IL. CRB-701 (SYS6002)
More than Ten Operating Room Procedures Complete with Multiple Sites Reordering and Scheduling Cases SmartFrame OR logo SmartFrame OR SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release for its SmartFrame OR™ Stereotactic System. “Expanding ClearPoint’s portfolio beyond